|
CLNS1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.205000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.649500E-02 |
| Normal-vs-Stage2 |
2.440000E-02 |
| Normal-vs-Stage3 |
1.095640E-01 |
| Normal-vs-Stage4 |
4.24409999999487E-06 |
| Stage1-vs-Stage2 |
1.240790E-01 |
| Stage1-vs-Stage3 |
6.215200E-01 |
| Stage1-vs-Stage4 |
5.057100E-03 |
| Stage2-vs-Stage3 |
5.066000E-01 |
| Stage2-vs-Stage4 |
2.226400E-01 |
| Stage3-vs-Stage4 |
8.595700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.178890E-03 |
| Normal-vs-AfricanAmerican |
3.416200E-03 |
| Normal-vs-Asian |
3.669000E-01 |
| Caucasian-vs-AfricanAmerican |
6.198000E-01 |
| Caucasian-vs-Asian |
9.314400E-01 |
| AfricanAmerican-vs-Asian |
9.305200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.094110E-02 |
| Normal-vs-Female |
4.03920000000557E-05 |
| Male-vs-Female |
5.764500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.459910E-03 |
| Normal-vs-Extreme_Weight |
5.189900E-02 |
| Normal-vs-Obese |
1.136290E-03 |
| Normal-vs-Extreme_Obese |
2.500800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.470500E-02 |
| Normal_Weight-vs-Obese |
7.379400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.520320E-02 |
| Extreme_Weight-vs-Obese |
7.308300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.768300E-02 |
| Obese-vs-Extreme_Obese |
1.961600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.276800E-03 |
| Normal-vs-Age(41-60Yrs) |
5.550300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.919990E-02 |
| Normal-vs-Age(81-100Yrs) |
3.231400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.570200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.698000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.330200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.729000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.377000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.258000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.243000E-03 |
| Normal-VS-Type2 PRCC |
4.418200E-01 |
| Normal-VS-KIRP CIMP |
1.458280E-03 |
| Normal-VS-Unclassified PRCC |
9.928400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.664240E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.640900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.580400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.937580E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.347800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.476100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.459200E-01 |
| Normal-vs-N1 |
4.618400E-03 |
| Normal-vs-N2 |
1.313860E-02 |
| N0-vs-N1 |
1.385520E-02 |
| N0-vs-N2 |
1.608810E-01 |
| N1-vs-N2 |
8.069800E-01 |
|
|
